Literature DB >> 29243776

Hypoxia promotes invasion of retinoblastoma cells in vitro by upregulating HIF-1α/MMP9 signaling pathway.

Y-Y Li1, Y-L Zheng.   

Abstract

OBJECTIVE: The aim of this study is to investigate the effect of hypoxia-inducible transcription factors-1α (HIF-1α)/matrix metalloproteinase 9 (MMP9) signaling pathway on hypoxia triggered invasion in retinoblastoma cell line HXO-RB44.
MATERIALS AND METHODS: HXO-RB44 cells were cultured under hypoxia conditions for 24 h. The effect of hypoxia on invasion ability of HXO-RB44 cells was monitored with transwell invasion assay; the mRNA and protein expression levels of HIF-1α and MMP9 were detected by Real-time polymerase chain reaction (RT-PCR) and Western blot; luciferase assay was performed to assess the MMP9 regulation by HIF-1α, and HIF-1α regulation by hypoxia. Furthermore, HIF-1α and MMP9 siRNA were used to investigate the effect of HIF-1α/MMP9 signaling on hypoxia-induced cell invasion.
RESULTS: The results demonstrated that hypoxia could promote HXO-RB44 cells invasion. The mRNA and protein level of HIF-1α and MMP9 were upregulated by hypoxia treatment, whereas HIF-1α and MMP9 siRNA could reverse these processes.
CONCLUSIONS: Hypoxia promotes retinoblastoma cell line HXO-RB44 invasion by activating HIF-1α/MMP9 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29243776     DOI: 10.26355/eurrev_201712_13921

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Brusatol Inhibits Proliferation and Metastasis of Colorectal Cancer by Targeting and Reversing the RhoA/ROCK1 Pathway.

Authors:  Rui-Jin Lu; Guo-Zhi Zhao; Rong Jiang; Shuang He; Hang Xu; Jia-Ming He; Yue Sun; Meng-Na Wu; Jian-Hua Ran; Di-Long Chen; Jing Li
Journal:  Biomed Res Int       Date:  2022-05-18       Impact factor: 3.246

2.  Evodiamine inhibits vasculogenic mimicry in HCT116 cells by suppressing hypoxia-inducible factor 1-alpha-mediated angiogenesis.

Authors:  Di Zeng; Peng Zhou; Rong Jiang; Xiao-Peng Li; Shi-Ying Huang; Dan-Yang Li; Guo-Li Li; Li-Sha Li; Shuang Zhao; Ling Hu; Jian-Hua Ran; Di-Long Chen; Ya-Ping Wang; Jing Li
Journal:  Anticancer Drugs       Date:  2021-03-01       Impact factor: 2.389

3.  Qi-Long-Tian formula extract alleviates symptoms of acute high-altitude diseases via suppressing the inflammation responses in rat.

Authors:  Xing Fu; Chunyan Yang; Bing Chen; Kexing Zeng; Siyuan Chen; Yi Fu
Journal:  Respir Res       Date:  2021-02-12

4.  Increasing Oxygen Partial Pressures Induce a Distinct Transcriptional Response in Human PBMC: A Pilot Study on the "Normobaric Oxygen Paradox".

Authors:  Deborah Fratantonio; Fabio Virgili; Alessandro Zucchi; Kate Lambrechts; Tiziana Latronico; Pierre Lafère; Peter Germonpré; Costantino Balestra
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

5.  RB1 loss triggers dependence on ESRRG in retinoblastoma.

Authors:  Matthew G Field; Jeffim N Kuznetsoff; Michelle G Zhang; James J Dollar; Michael A Durante; Yoseph Sayegh; Christina L Decatur; Stefan Kurtenbach; Daniel Pelaez; J William Harbour
Journal:  Sci Adv       Date:  2022-08-19       Impact factor: 14.957

6.  A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas.

Authors:  Peng Ren; Jing-Ya Wang; Zhi-Rui Zeng; Nan-Xi Li; Hong-Lei Chen; Xin-Ge Peng; Ujjal K Bhawal; Wen-Zhi Guo
Journal:  Front Genet       Date:  2022-09-02       Impact factor: 4.772

7.  Malic Enzyme 1 Is Associated with Tumor Budding in Oral Squamous Cell Carcinomas.

Authors:  Chie Nakashima; Tadaaki Kirita; Kazuhiko Yamamoto; Shiori Mori; Yi Luo; Takamitsu Sasaki; Kiyomu Fujii; Hitoshi Ohmori; Isao Kawahara; Takuya Mori; Kei Goto; Shingo Kishi; Rina Fujiwara-Tani; Hiroki Kuniyasu
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.